Developer docs
API playgroundTry for free, no card

Search company profiles

Humax Pharmaceutical

Full company profile

uuid000z8z3

Namestring
Humax Pharmaceutical
Legal namestring
HUMAX PHARMACEUTICAL S.A.
Websiteurl
humax.com.co
Company typeenum
Public
Founded yearint
2002
Descriptiontext

Humax Pharmaceutical S.A. is a Colombian pharmaceutical laboratory and wholly-owned subsidiary (filial) of Bausch Health Companies Inc., headquartered in La Estrella, Antioquia. The company was founded in 2002 and has operated for over 22 years in the Colombian market, manufacturing and commercializing branded generic pharmaceutical products across multiple therapeutic areas including dermatology (Sulzinc, Caladryl), allergy (Fexodina), pain management (Naprofen, Neuronox), antifungals (Terbifin), and nutritional supplements (Bedoyecta). Its core technology is pharmaceutical formulation and manufacturing, augmented by a corporate Pharmacovigilance Unit operating under INVIMA and international standards for adverse event reporting and drug safety monitoring. The company employs 251-500 people and focuses on delivering effective, reliable medications at reasonable prices for the general Colombian patient population, with a stated commitment to therapeutic areas "few in the industry consider."

Humax operates a traditional pharmaceutical sales-led go-to-market model, distributing products through pharmacy and healthcare networks across Colombia on a one-time-purchase basis. Its customer base is the broad Colombian patient population (horizontal segmentation), reached via distributor/wholesale channels and supported by organic social media presence (LinkedIn, Instagram, Facebook) and a corporate blog. The company is governed under Colombian corporate law as a Sociedad Anónima (S.A.) and is subject to INVIMA regulatory oversight. Strategic alignment with its Bausch Health parent is evidenced by visits from global VPs of Quality and Manufacturing and structured Town Hall alignment events. Recent operational emphasis has been on internal workforce development, including 250+ employee promotions across 2023-2025, English language certification via Idiomas EAFIT, and a mentoring program with Aristos Consultores that has trained 30+ mentors.

Short descriptiontext

Humax Pharmaceutical S.A. is a Colombian subsidiary of Bausch Health Companies Inc. that manufactures and distributes branded generic pharmaceuticals across dermatology, allergy, pain management, and supplements, serving the general Colombian patient population through pharmacy and healthcare networks.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersLa Estrella, Colombia
HQ citystring
La Estrella
HQ countrystring
Colombia
HQ regionstring
Latin America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
branded generic pharmaceuticals, pharmaceutical manufacturing, dermatology medications, over-the-counter drugs, nutritional supplements
Industry3 codes
PRIMARYHLAIABAL
Generic Hospital & Institutional Products
SECONDARYCRADAMAC
OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYCRADAMAD
Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Manufacturing
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Products Sales
TypeOne Time License
Description

Manufacturing, distribution and sale of branded generic pharmaceutical products including over-the-counter and prescription medications across multiple therapeutic areas including dermatology, allergy, pain management, and nutritional supplements

humax.com.co
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D
Pricing details1 tier
1Pharmaceutical products at reasonable market prices
ModelOtherBilling cadencePay-as-you-go
Notes

Products available at reasonable prices in the pharmaceutical market

humax.com.co
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1Sulzinc
Description

Pharmaceutical brand product

humax.com.co
+6 more records
Core offering1 text field

Humax Pharmaceutical manufactures, distributes, and sells branded generic pharmaceutical products for the Colombian market across multiple therapeutic areas including dermatology, allergy, pain management, neurology, antifungals, and nutritional supplements. Its portfolio includes established brands such as Caladryl, Sulzinc, Fexodina, Naprofen, Neuronox, Terbifin, and Bedoyecta, sold through pharmacy and healthcare outlets at affordable prices.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • More than 250 employees promoted between 2023, 2024, and 2025
+1 more record
Product overview1 text field

Humax Pharmaceutical is a Colombian pharmaceutical company and subsidiary of Bausch Health Companies Inc. The company manufactures and commercializes a portfolio of pharmaceutical products including medications for dermatological conditions (Caladryl), anti-inflammatory treatments (Naprofen), antihistamines (Fexodina), antifungals (Terbifin), topical treatments (Sulzinc), neurological products (Neuronox), and vitamins/supplements (Bedoyecta). With over 22 years of history, the company is committed to providing effective and reliable medications at reasonable prices, focusing on products that address important areas of human health.

Product and service8 records
1Sulzinc
CategoryDermatology medication
Description

Humax Pharmaceutical's zinc oxide-based dermatological product brand for topical skin treatment, sold through pharmacies in Colombia.

2Caladryl Loción
CategoryDermatology medication
Description

Topical calamine-based anti-itch lotion product under the Caladryl sub-brand in Humax Pharmaceutical's portfolio, sold through Colombian pharmacies.

3Caladryl Clear
CategoryDermatology medication
Description

Pharmaceutical product variant under the Caladryl sub-brand for dermatological use, sold through Colombian pharmacies.

4Fexodina
CategoryAllergy medication
Description

Humax Pharmaceutical's antihistamine / allergy medication brand sold through Colombian pharmacies for the treatment of allergic conditions.

5Terbifin
CategoryAntifungal medication
Description

Humax Pharmaceutical's antifungal medication brand sold through Colombian pharmacies for the treatment of fungal infections.

6Naprofen
CategoryPain management medication
Description

Humax Pharmaceutical's NSAID / anti-inflammatory pain relief medication brand sold through Colombian pharmacies.

7Neuronox
CategoryNeurology medication
Description

Humax Pharmaceutical's neurological / pain management product brand sold through Colombian pharmacies.

8Bedoyecta
CategoryNutritional supplement
Description

Humax Pharmaceutical's B-complex vitamin nutritional supplement brand sold through Colombian pharmacies.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Humax Pharmaceutical is a subsidiary (filial) of Bausch Health Companies Inc., a global pharmaceutical company. This provides Humax with access to global resources, pharmaceutical expertise, and international quality standards. Humax operates under the corporate structure and strategic direction of Bausch Health.

2Idiomas EAFIT
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Language training partner providing English language education programs for Humax employees. The partnership has yielded results with employees completing C1 level certification, who then motivate others to achieve the same level.

humax.com.co
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Mentoring program partner that has helped train over 30 mentors who accompany employees in their development plans. The partnership strengthens leadership development and career growth initiatives.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Sandoz
TypeBroad incumbent
Description

Global generics and biosimilars company spun out of Novartis; broad OTC and prescription generic footprint across geographies. Comparable through generics-driven business model and OTC franchise strategy though operating globally.

2EMS
TypeRegional player
Description

Brazil's largest domestic pharmaceutical company and one of the top generic manufacturers in LATAM, with broad OTC and prescription branded-generic lines. Comparable through portfolio breadth and branded-generic GTM, though Brazil-focused.

3Procaps
TypeDirect peer
Description

LATAM pharmaceutical contract development and manufacturing organization with branded generic products; comparable as a Colombia-headquartered pharma manufacturer with both OTC and prescription exposure.

4Lafrancol
TypeDirect peer
Description

Colombian pharmaceutical company focused on consumer health, OTC, and personal care products with broad pharmacy distribution — overlapping portfolio categories and distribution channels with Humax in the Colombian market.

5Eurofarma
TypeRegional player
Description

Brazil-headquartered pan-LATAM pharmaceutical manufacturer with branded generics, OTC, and hospital portfolios. Comparable in business model (branded generics, multi-country LATAM distribution) though geographically anchored to Brazil.

TypeDirect peer
Description

Colombia's largest domestic pharmaceutical company, manufacturing and marketing branded generics and OTC products across similar therapeutic categories (analgesics, dermatology, vitamins). Directly competes with Humax for shelf space and physician/pharmacy relationships in Colombia.

TypeDirect peer
Description

LATAM-focused generic pharmaceutical manufacturer with strong Colombia presence; competes head-to-head with Humax in the same OTC and prescription generic categories (pain, allergy, dermatology).

TypeRegional player
Description

Argentine pharmaceutical group with significant LATAM presence across branded generics, OTC, and specialty therapeutics. Comparable as a LATAM multi-country pharma operator with OTC and ethical portfolios similar to Humax.

TypeBroad incumbent
Description

Global generic pharmaceutical leader with broad OTC, generic, and specialty portfolios. Comparable through its generic-pharma business model and OTC/prescription split, though operating at vastly larger global scale.

10Asofarma
TypeRegional player
Description

Mexican pharmaceutical company with branded generics, OTC, and consumer health products distributed across Mexico and selected LATAM markets. Similar branded-generic, multi-therapeutic GTM though primarily Mexico-based.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Humax Pharmaceutical

Pharmaceutical Manufacturinghumax.com.co

Humax Pharmaceutical S.A. is a Colombian subsidiary of Bausch Health Companies Inc. that manufactures and distributes branded generic pharmaceuticals across dermatology, allergy, pain management, and supplements, serving the general Colombian patient population through pharmacy and healthcare networks.

What Humax Pharmaceutical does

Humax Pharmaceutical S.A. is a Colombian pharmaceutical laboratory and wholly-owned subsidiary (filial) of Bausch Health Companies Inc., headquartered in La Estrella, Antioquia. The company was founded in 2002 and has operated for over 22 years in the Colombian market, manufacturing and commercializing branded generic pharmaceutical products across multiple therapeutic areas including dermatology (Sulzinc, Caladryl), allergy (Fexodina), pain management (Naprofen, Neuronox), antifungals (Terbifin), and nutritional supplements (Bedoyecta). Its core technology is pharmaceutical formulation and manufacturing, augmented by a corporate Pharmacovigilance Unit operating under INVIMA and international standards for adverse event reporting and drug safety monitoring. The company employs 251-500 people and focuses on delivering effective, reliable medications at reasonable prices for the general Colombian patient population, with a stated commitment to therapeutic areas "few in the industry consider."

Humax operates a traditional pharmaceutical sales-led go-to-market model, distributing products through pharmacy and healthcare networks across Colombia on a one-time-purchase basis. Its customer base is the broad Colombian patient population (horizontal segmentation), reached via distributor/wholesale channels and supported by organic social media presence (LinkedIn, Instagram, Facebook) and a corporate blog. The company is governed under Colombian corporate law as a Sociedad Anónima (S.A.) and is subject to INVIMA regulatory oversight. Strategic alignment with its Bausch Health parent is evidenced by visits from global VPs of Quality and Manufacturing and structured Town Hall alignment events. Recent operational emphasis has been on internal workforce development, including 250+ employee promotions across 2023-2025, English language certification via Idiomas EAFIT, and a mentoring program with Aristos Consultores that has trained 30+ mentors.

Humax Pharmaceutical firmographics

Firmographics
Name
Humax Pharmaceutical
Legal name
HUMAX PHARMACEUTICAL S.A.
Website
https://humax.com.co
Company type
Public
Founded year
2002
Operating status
Operating
Headcount range
251–500 employees
Short description
Humax Pharmaceutical S.A. is a Colombian subsidiary of Bausch Health Companies Inc. that manufactures and distributes branded generic pharmaceuticals across dermatology, allergy, pain management, and supplements, serving the general Colombian patient population through pharmacy and healthcare networks.
Ownership category
akta.pro rank

Humax Pharmaceutical industry classification

Industry
Product category
Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIABAL
Generic Hospital & Institutional Products
SECONDARYCRADAMAC
OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYCRADAMAD
Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)

Keywords

  • Branded generic pharmaceuticals
  • Pharmaceutical manufacturing
  • Dermatology medications
  • Over-the-counter drugs
  • Nutritional supplements

Where Humax Pharmaceutical is headquartered

Location

Headquarters

HQ city
La Estrella
HQ country
Colombia
HQ region
Latin America

Offices2 records

Markets served

Humax Pharmaceutical business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Pharmaceutical Products Sales: Manufacturing, distribution and sale of branded generic pharmaceutical products including over-the-counter and prescription medications across multiple therapeutic areas including dermatology, allergy, pain management, and nutritional supplements

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goPharmaceutical products at reasonable market prices

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Humax Pharmaceutical product offering

Product offering

Core offering

Humax Pharmaceutical manufactures, distributes, and sells branded generic pharmaceutical products for the Colombian market across multiple therapeutic areas including dermatology, allergy, pain management, neurology, antifungals, and nutritional supplements. Its portfolio includes established brands such as Caladryl, Sulzinc, Fexodina, Naprofen, Neuronox, Terbifin, and Bedoyecta, sold through pharmacy and healthcare outlets at affordable prices.

Product overview

Humax Pharmaceutical is a Colombian pharmaceutical company and subsidiary of Bausch Health Companies Inc. The company manufactures and commercializes a portfolio of pharmaceutical products including medications for dermatological conditions (Caladryl), anti-inflammatory treatments (Naprofen), antihistamines (Fexodina), antifungals (Terbifin), topical treatments (Sulzinc), neurological products (Neuronox), and vitamins/supplements (Bedoyecta). With over 22 years of history, the company is committed to providing effective and reliable medications at reasonable prices, focusing on products that address important areas of human health.

Differentiator

Problem solved

Functional benefit

Brands

  • Sulzinc: Pharmaceutical brand product
  • Caladryl
  • Fexodina
  • Terbifin
  • Naprofen
  • Neuronox
  • Bedoyecta

Products and services

  • Sulzinc Humax Pharmaceutical's zinc oxide-based dermatological product brand for topical skin treatment, sold through pharmacies in Colombia.
  • Caladryl Loción Topical calamine-based anti-itch lotion product under the Caladryl sub-brand in Humax Pharmaceutical's portfolio, sold through Colombian pharmacies.
  • Caladryl Clear Pharmaceutical product variant under the Caladryl sub-brand for dermatological use, sold through Colombian pharmacies.
  • Fexodina Humax Pharmaceutical's antihistamine / allergy medication brand sold through Colombian pharmacies for the treatment of allergic conditions.
  • Terbifin Humax Pharmaceutical's antifungal medication brand sold through Colombian pharmacies for the treatment of fungal infections.
  • Naprofen Humax Pharmaceutical's NSAID / anti-inflammatory pain relief medication brand sold through Colombian pharmacies.
  • Neuronox Humax Pharmaceutical's neurological / pain management product brand sold through Colombian pharmacies.
  • Bedoyecta Humax Pharmaceutical's B-complex vitamin nutritional supplement brand sold through Colombian pharmacies.

Quantifiable outcome

  • More than 250 employees promoted between 2023, 2024, and 2025
  • +1 more outcomes

Companies that use Humax Pharmaceutical

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Humax Pharmaceutical technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Humax Pharmaceutical partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Bausch Health Companies Inc.coreStrategic or Co-development PartnerHumax Pharmaceutical is a subsidiary (filial) of Bausch Health Companies Inc., a global pharmaceutical company. This provides Humax with access to global resources, pharmaceutical expertise, and international quality standards. Humax operates under the corporate structure and strategic direction of Bausch Health.
  • Idiomas EAFITminorStrategic or Co-development PartnerLanguage training partner providing English language education programs for Humax employees. The partnership has yielded results with employees completing C1 level certification, who then motivate others to achieve the same level.
  • Aristos Consultores de Gerencia S.A.minorImplementation/ SI/ Consulting PartnerMentoring program partner that has helped train over 30 mentors who accompany employees in their development plans. The partnership strengthens leadership development and career growth initiatives.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Humax Pharmaceutical competitors and assessment

Company assessment

Broad incumbents

  • Sandoz: Global generics and biosimilars company spun out of Novartis; broad OTC and prescription generic footprint across geographies. Comparable through generics-driven business model and OTC franchise strategy though operating globally.
  • Teva Pharmaceutical Industries: Global generic pharmaceutical leader with broad OTC, generic, and specialty portfolios. Comparable through its generic-pharma business model and OTC/prescription split, though operating at vastly larger global scale.

Regional players

  • EMS: Brazil's largest domestic pharmaceutical company and one of the top generic manufacturers in LATAM, with broad OTC and prescription branded-generic lines. Comparable through portfolio breadth and branded-generic GTM, though Brazil-focused.
  • Eurofarma: Brazil-headquartered pan-LATAM pharmaceutical manufacturer with branded generics, OTC, and hospital portfolios. Comparable in business model (branded generics, multi-country LATAM distribution) though geographically anchored to Brazil.
  • Bagó: Argentine pharmaceutical group with significant LATAM presence across branded generics, OTC, and specialty therapeutics. Comparable as a LATAM multi-country pharma operator with OTC and ethical portfolios similar to Humax.
  • Asofarma: Mexican pharmaceutical company with branded generics, OTC, and consumer health products distributed across Mexico and selected LATAM markets. Similar branded-generic, multi-therapeutic GTM though primarily Mexico-based.

Direct peers

  • Procaps: LATAM pharmaceutical contract development and manufacturing organization with branded generic products; comparable as a Colombia-headquartered pharma manufacturer with both OTC and prescription exposure.
  • Lafrancol: Colombian pharmaceutical company focused on consumer health, OTC, and personal care products with broad pharmacy distribution — overlapping portfolio categories and distribution channels with Humax in the Colombian market.
  • Tecnoquímicas: Colombia's largest domestic pharmaceutical company, manufacturing and marketing branded generics and OTC products across similar therapeutic categories (analgesics, dermatology, vitamins). Directly competes with Humax for shelf space and physician/pharmacy relationships in Colombia.
  • Genfar: LATAM-focused generic pharmaceutical manufacturer with strong Colombia presence; competes head-to-head with Humax in the same OTC and prescription generic categories (pain, allergy, dermatology).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Humax Pharmaceutical social profiles

Digital presence

Humax Pharmaceutical compliance and trust

Trust signal

Compliance1 record

Humax Pharmaceutical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Humax Pharmaceutical leadership team

Management profile

Number of profiles

Profiles3 records

Humax Pharmaceutical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Humax Pharmaceutical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Humax Pharmaceutical

What does Humax Pharmaceutical do?

Humax Pharmaceutical manufactures, distributes, and sells branded generic pharmaceutical products for the Colombian market across multiple therapeutic areas including dermatology, allergy, pain management, neurology, antifungals, and nutritional supplements. Its portfolio includes established brands such as Caladryl, Sulzinc, Fexodina, Naprofen, Neuronox, Terbifin, and Bedoyecta, sold through pharmacy and healthcare outlets at affordable prices.

Is Humax Pharmaceutical a public or private company?

Humax Pharmaceutical is a public company. It is classified as corporate owned and is currently operating.

When was Humax Pharmaceutical founded?

Humax Pharmaceutical was founded in 2002. It employs 251 to 500 people.

Where is Humax Pharmaceutical based?

Humax Pharmaceutical is headquartered in La Estrella, Colombia, in the Latin America region.

How does Humax Pharmaceutical make money?

One revenue line is on record: pharmaceutical Products Sales.

Who are Humax Pharmaceutical's main competitors?

Broad incumbents on record are Sandoz and Teva Pharmaceutical Industries. Regional players are EMS, Eurofarma, Bagó and Asofarma. Direct peers are Procaps, Lafrancol, Tecnoquímicas and Genfar.

Does Humax Pharmaceutical have an API?

No public API is recorded for Humax Pharmaceutical.

What industry is Humax Pharmaceutical in?

Humax Pharmaceutical's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIABAL, Generic Hospital & Institutional Products, with a secondary code of CRADAMAC, OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales